Cell Expansion Technologies Market Size, Share, Growth, And Industry Analysis, By Type (Reagents, Media, Sera, Disposables, and Cell Expansion Technologies), By Application (Clinical diagnostics, Drug discovery and development, Regenerative medicine, and Others), Regional Forecast From 2025 To 2033

• 

   Request a Free Sample To Get More Information on this Market

CELL EXPANSION TECHNOLOGIES MARKET REPORT OVERVIEW

The global cell expansion technologies market size was USD 18.06 billion in 2024 and is expected to reach USD 42.93 billion in 2033, at CAGR of 10.1% during the forecast period.

The worldwide cell expansion market can be roughly divided into human cells and animal cells depending on the type of cell. Stem cells and differentiated cells are additional categories for the human cell. Due to the increased frequency of numerous chronic diseases and government assistance, the human stem cell category commands the largest revenue share in the market. Cell expansion, which supports medical research, is the large-scale artificial generation of daughter cells from a single cell. In order for a cell to expand, new cell wall material must be produced, and the wall must be gradually loosened to allow for stretching and area growth. Cell expansion is employed in a variety of life science research and development projects, including medication discovery and screening.

As key market players conduct more research and development on the usage of cell therapy approach for the creation of vaccines, antibiotics, and medicines, the market for cell expansion is anticipated to expand. There are several uses for cell multiplication, including the treatment of diseases including diabetes, cancer, and others.

COVID-19 IMPACT

"Strain on Supply Chain to Hamper Market Growth"

Due to restrictions in the medicine supply chain during the COVID-19 pandemic, it is anticipated that the COVID-19 pandemic will restrain the growth of the worldwide cell expansion market. For instance, the successful steps implemented to stop the COVID-19 pandemic's spread have ultimately had a negative impact on the drug supply chain, according to statistics provided by the United Nations Office on Drugs and Crime in July 2020. At the retail level, numerous nations around the world have reported a general scarcity of various sorts of medications. The market for acute bacterial skin and skin structure infections is projected to suffer as a result of supply chain issues affecting drug production and transportation.

The financial standing of companies in the healthcare industries has been harmed by the global lockdown caused by the coronavirus (COVID-19) epidemic. Due to the COVID-19 pandemic, players in the worldwide cell expansion industry are seeing significant difficulties on numerous fronts. The primary obstacles include the lack of raw materials needed to manufacture the tools and accessories used in cell expansion applications, as well as problems with the transportation system.

LATEST TRENDS

"Usage of the Technology in Treating Cancer to Propel Market Growth"

Cell division has a variety of applications, including the treatment of conditions including diabetes, cancer, and other illnesses. White blood cells are obtained from donors through a procedure known as leukapheresis in cell therapy operations. To facilitate gene transfer and the reprogramming of T cells to express CARs, specific T cell phenotypes from white blood cells are identified and activated. It is much more likely to isolate a more desirable early memory T cell population using allogeneic processes, which can lead to higher cellular production and overall better therapy efficacy.

CELL EXPANSION TECHNOLOGIES MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into reagents, media, sera, disposables and cell expansion technologies.

In terms of product, cell expansion technologies is the largest segment.

By Application Analysis

Based on application, the market can be divided into clinical diagnostics, drug discovery and development, regenerative medicine and others.

In terms of application, clinical diagnostics is the largest segment.

DRIVING FACTORS

"Development of New Technologies to Augment Market Growth"

For industry participants in the worldwide cell expansion market, the development of new technologies in cell expansion is anticipated to present attractive growth prospects. One such example is the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA), a state-of-the-art novel process for scalable manufacture of transfection-free adeno-associated virus (AAV) at Good Manufacturing Practice (GMP) grade, by WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec. TESSA, created by OXGENE in the U.K., a WuXi Advanced Therapies company, will hasten the production of AAV and reduce the cost of producing cell and gene therapies, enabling global customers to provide more affordable cutting-edge treatments to patients as soon as is practical.

"Increase in Funding for Stem Cell Research Generates Potential Opportunities for the Market"

Stem cells are increasingly being used to treat various illnesses and chronic disorders that afflict millions of people worldwide. One of the main drivers fueling the market's expansion is ongoing research in the field of stem cells. Governments and other private groups are funding considerable stem cell research, which is pushing market participants to carve their niches in the world market by treating a range of chronic conditions. In the approaching years, there are numerous growth prospects anticipated for the market for stem cells. It is projected that the rising prevalence of chronic diseases will resurrect cell expansion technologies market growth.

RESTRAINING FACTORS

"Killing of Human Embryos During the Process to Impede Market Expansion"

Animal and human cells are also utilized to evaluate medicines for in vivo toxicity and pharmacokinetics in animals and humans. Furthermore, stem cell research uses human embryos for clinical purposes, which frequently results in the killing of human embryos. Stringent restrictions have been created by ethical authorities such as The Human Tissue Authority (HTA), the Human Fertilization and Embryology Authority (HFEA), and others in numerous nations across the world to supervise these operations.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

CELL EXPANSION TECHNOLOGIES MARKET REGIONAL INSIGHTS

"North America to Dominate the Market Due to Potential Market Players"

Due to the rising number of cell and gene therapy production facilities that market players are buying up in the region,North America is predicted to keep a prominent position among the regions during the projected period and owns largest portion of cell expansion technologies market share. In order to purchase a cutting-edge cell and gene therapy commercial manufacturing facility in Longmont, Colorado, the U.S., AGC Biologics, a significant global biopharmaceutical contract development and manufacturing organization (CDMO), signed a purchase agreement with Novartis Gene Therapies, a division of Novartis AG. After comprehensive due diligence, the facility will give AGC Biologics significantly more capacity and space to continue developing its end-to-end Cell and Gene Therapy (C>) offering and guarantee supply security for present and future C> clients.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

The launch of a new medium for cell expansion and maintenance by major players is anticipated to fuel the growth of the global cell expansion market. For instance, Bio-Techne Corporation announced the release of a new medium for the expansion and maintenance of induced pluripotent stem cells (iPSCs), which can be used in both research and translational workflows. The company develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostic, and bioprocessing markets. The iPSC expansion medium from ExCellerate is the newest product in Bio-line Techne's of regenerative medicine products.

List of Top Cell Expansion Technologies Companies

• Becton (U.S.)
• Dickinson (U.S.)
• GE Healthcare (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Corning Inc (U.S.)
• Danaher Corp (U.S.)
• Merck Millipore (U.S.)
• Terumo BCT (U.S.)
• STEMCELL Technologies (Canada)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.